Arvind Dasari

Dr. Dasari is a medical oncologist in the Dept of Gastrointestinal Medical Oncology at the University of Texas MD Anderson Cancer Center.
As a Southwest Oncology Group (SWOG) and NRG Oncology member, he serves on their GI, Colorectal Cancers, and Neuroendocrine Committees.
He serves as the SWOG subcommittee co-Chair for NET and on the NET Task Force
His primary research focus is phase I-III clinical trial development using novel therapeutics inclusive of blood and tissue correlatives for biomarker discovery and enhanced drug utilization in treating gastrointestinal malignancies with a focus on colorectal and neuroendocrine cancers.
He leads several ongoing trials in neuroendocrine tumors and colorectal cancers